Showing results (91-100 of 107) with videos related to
Sort By:
Pageof 11
Diabetes Care|January 21, 2021
Risk of Blindness Among Patients With Diabetes and Newly Diagnosed Diabetic RetinopathyCharles C Wykoff, Rahul N Khurana, Quan Dong Nguyen, et al.American Journal of Ophthalmology|March 3, 2021
Tube Versus Trabeculectomy IRISⓇ Registry 1-Year Composite Outcome Analysis with Comparisons to the Randomized Controlled TrialElizabeth A Vanner, Catherine Q Sun, Matthew J McSoley, et al.American Journal of Ophthalmology|December 11, 2020
The Tube Versus Trabeculectomy IRIS® Registry Study: Cohort Selection and Follow-up and Comparisons to the Randomized Controlled TrialElizabeth A Vanner, Catherine Q Sun, Matthew J McSoley, et al.The Journal of Urology|April 20, 2016
Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational ManagementScott P Kelly, Stephen K Van Den Eeden, Richard M Hoffman, et al.Breast Cancer Research and Treatment|April 4, 2018
Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patientsMarc D Schwartz, Beth N Peshkin, Claudine Isaacs, et al.Ophthalmology|February 18, 2021
Demographic and Clinical Characteristics Associated with Minimally Invasive Glaucoma Surgery Use: An Intelligent Research in Sight (IRIS®) Registry Retrospective Cohort AnalysisMildred M G Olivier, Oluwatosin U Smith, Clarisse C Croteau-Chonka, et al.Frontiers in Oncology|December 6, 2016
Sex Steroid Hormone Single-Nucleotide Polymorphisms, Pesticide Use, and the Risk of Prostate Cancer: A Nested Case-Control Study within the Agricultural Health StudyCarol H Christensen, Kathryn Hughes Barry, Gabriella Andreotti, et al.Breast Cancer Research and Treatment|January 3, 2020
Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patientsMara Tynan, Beth N Peshkin, Claudine Isaacs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 27, 2012
Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trialKathryn L Taylor, George Luta, Anthony B Miller, et al.JAMA Network Open|May 21, 2026
Axitinib-Pembrolizumab and Adverse Event Management in Patients With Advanced Renal Cell CarcinomaNeil J Shah, Yaa Ababio, Anthony Eccleston, et al.Pageof 11